148 related articles for article (PubMed ID: 20033262)
1. Preclinical investigation of tolerance and antitumour activity of new fluorodeoxyglucose-coupled chlorambucil alkylating agents.
Miot-Noirault E; Reux B; Debiton E; Madelmont JC; Chezal JM; Coudert P; Weber V
Invest New Drugs; 2011 Jun; 29(3):424-33. PubMed ID: 20033262
[TBL] [Abstract][Full Text] [Related]
2. Linker structure-activity relationships in fluorodeoxyglucose chlorambucil conjugates for tumor-targeted chemotherapy.
El Hilali M; Reux B; Debiton E; Leal F; Galmier MJ; Vivier M; Chezal JM; Miot-Noirault E; Coudert P; Weber V
Bioorg Med Chem; 2017 Oct; 25(20):5692-5708. PubMed ID: 28927903
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxic properties of new fluorodeoxyglucose-coupled chlorambucil derivatives.
Reux B; Weber V; Galmier MJ; Borel M; Madesclaire M; Madelmont JC; Debiton E; Coudert P
Bioorg Med Chem; 2008 May; 16(9):5004-20. PubMed ID: 18424156
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro efficacy of transferrin conjugates of the anticancer drug chlorambucil.
Beyer U; Roth T; Schumacher P; Maier G; Unold A; Frahm AW; Fiebig HH; Unger C; Kratz F
J Med Chem; 1998 Jul; 41(15):2701-8. PubMed ID: 9667961
[TBL] [Abstract][Full Text] [Related]
5. Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo.
Ma ZY; Wang DB; Song XQ; Wu YG; Chen Q; Zhao CL; Li JY; Cheng SH; Xu JY
Eur J Med Chem; 2018 Sep; 157():1292-1299. PubMed ID: 30195239
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of novel paclitaxel-chlorambucil hybrids.
Wittman MD; Kadow JF; Vyas DM; Lee FL; Rose WC; Long BH; Fairchild C; Johnston K
Bioorg Med Chem Lett; 2001 Mar; 11(6):811-4. PubMed ID: 11277526
[TBL] [Abstract][Full Text] [Related]
7. Arresting cancer proliferation by small-molecule gene regulation.
Dickinson LA; Burnett R; Melander C; Edelson BS; Arora PS; Dervan PB; Gottesfeld JM
Chem Biol; 2004 Nov; 11(11):1583-94. PubMed ID: 15556009
[TBL] [Abstract][Full Text] [Related]
8. Chlorambucil in chronic lymphocytic leukemia: mechanism of action.
Begleiter A; Mowat M; Israels LG; Johnston JB
Leuk Lymphoma; 1996 Oct; 23(3-4):187-201. PubMed ID: 9031099
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of chlorambucil loaded graphene- oxide nanocarrier and its application for improved antitumor activity.
Singh G; Nenavathu BP; Imtiyaz K; Moshahid A Rizvi M
Biomed Pharmacother; 2020 Sep; 129():110443. PubMed ID: 32593130
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of DNA alkylation by conjugates between pyrrole-imidazole hairpin polyamides and chlorambucil or seco-CBI.
Minoshima M; Bando T; Shinohara K; Kashiwazaki G; Nishijima S; Sugiyama H
Bioorg Med Chem; 2010 Feb; 18(3):1236-43. PubMed ID: 20074970
[TBL] [Abstract][Full Text] [Related]
11. Thermoresponsive chlorambucil derivatives for tumour targeting.
Clavel CM; Zava O; Schmitt F; Kenzaoui BH; Nazarov AA; Juillerat-Jeanneret L; Dyson PJ
Angew Chem Int Ed Engl; 2011 Jul; 50(31):7124-7. PubMed ID: 21688360
[No Abstract] [Full Text] [Related]
12. Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studies.
Peyrode C; Weber V; David E; Vidal A; Auzeloux P; Communal Y; Dauplat MM; Besse S; Gouin F; Heymann D; Chezal JM; Rédini F; Miot-Noirault E
Invest New Drugs; 2012 Aug; 30(4):1782-90. PubMed ID: 21499733
[TBL] [Abstract][Full Text] [Related]
13. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
[TBL] [Abstract][Full Text] [Related]
14. Chlorambucil.
National Toxicology Program
Rep Carcinog; 2011; 12():90-1. PubMed ID: 21850122
[No Abstract] [Full Text] [Related]
15. Liposome-like nanocapsules of dual drug-tailed betaine for cancer therapy.
Fang S; Niu Y; Zhang W; Zhang Y; Yu L; Zhang Y; Li X
Int J Pharm; 2015 Sep; 493(1-2):460-5. PubMed ID: 26256150
[TBL] [Abstract][Full Text] [Related]
16. Protein ruthenation and DNA alkylation: chlorambucil-functionalized RAPTA complexes and their anticancer activity.
Nazarov AA; Meier SM; Zava O; Nosova YN; Milaeva ER; Hartinger CG; Dyson PJ
Dalton Trans; 2015 Feb; 44(8):3614-23. PubMed ID: 25407500
[TBL] [Abstract][Full Text] [Related]
17. Stepwise dual stimuli triggered dual drug release by a single naphthalene based two-photon chromophore to reverse MDR for alkylating agents with dual surveillance in uncaging steps.
Roy B; Kundu M; Singh AK; Singha T; Bhattacharya S; Datta PK; Mandal M; Singh NDP
Chem Commun (Camb); 2019 Oct; 55(87):13140-13143. PubMed ID: 31617528
[TBL] [Abstract][Full Text] [Related]
18. Chlorambucil.
Rep Carcinog; 2004; 11():III47-8. PubMed ID: 21089821
[No Abstract] [Full Text] [Related]
19. Hybrid of DNA-targeting Chlorambucil with Pt(IV) Species to Reverse Drug Resistance.
Chen F; Xu G; Qin X; Jin X; Gou S
J Pharmacol Exp Ther; 2017 Nov; 363(2):221-239. PubMed ID: 28916659
[TBL] [Abstract][Full Text] [Related]
20. Alkylating benzamides with melanoma cytotoxicity: experimental chemotherapy in a mouse melanoma model.
Wolf M; Eskerski H; Bauder-Wüst U; Haberkorn U; Eisenhut M
Melanoma Res; 2006 Dec; 16(6):487-96. PubMed ID: 17119449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
